Evidence map›Paper›PMID 38019303›Full record

ArticleEJNMMI research2023

[

Samuel Deshayes, Caroline Baugé, Pierre-Antoine Dupont, Christophe Simard, Hanan Rida, Hubert de Boysson, Alain Manrique, Achille Aouba

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in EJNMMI research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 57% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Samuel DeshayesDepartment of Internal Medicine and Clinical Immunology, Normandie University, UNICAEN, CHU de Caen Normandie - Université Basse Normandie, Avenue de la Côte de Nacre, 14000, CAEN, France. samuel.deshayes@gmail.com.
Caroline BaugéNormandie University, UNICAEN, CHU de Caen Normandie, UR4650 PSIR, Caen, France.
Pierre-Antoine DupontNormandie University, UNICAEN, CHU de Caen Normandie, UR4650 PSIR, Caen, France.
Christophe SimardNormandie University, UNICAEN, CHU de Caen Normandie, UR4650 PSIR, Caen, France.
Hanan RidaNormandie University, UNICAEN, CHU de Caen Normandie, UR4650 PSIR, Caen, France.
Hubert de BoyssonDepartment of Internal Medicine and Clinical Immunology, Normandie University, UNICAEN, CHU de Caen Normandie - Université Basse Normandie, Avenue de la Côte de Nacre, 14000, CAEN, France.
Alain Manrique *Normandie University, UNICAEN, CHU de Caen Normandie, UR4650 PSIR, Caen, France.
Achille Aouba *Department of Internal Medicine and Clinical Immunology, Normandie University, UNICAEN, CHU de Caen Normandie - Université Basse Normandie, Avenue de la Côte de Nacre, 14000, CAEN, France. aouba-a@chu-caen.fr.
Normandie Université · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMetabolic imaging is routinely used to demonstrate aortitis in patients with giant-cell arteritis. We aimed to investigate the preclinical model of aortitis in BALB/c IL1rn

results[

conclusionsIn addition to the involvement of interleukin-1β and -6 in IL1rn

Indexed as

AortitisGiant-cell arteritisIL1rn −/− aortitis mouse modelInterleukin-1PET-MR

Identifiers

PMID38019303
PMCPMC10687326
OpenAlexW4389140179

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.